Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02646618 · ClinicalTrials.gov registry record · NA

Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention

A NA study, sponsored by University of Connecticut.

Completed
Registry status
NA
Development phase
329
Enrollment target

NCT02646618: Completed NA study, sponsored by University of Connecticut.

NCT02646618 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 329 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02646618, a NA study, has completed, sponsored by University of Connecticut.

COMPLETED
Registry status
NA
Development phase
329 participants
Enrollment target

Study Summary

The present study is a non-inferiority trial comparing the efficacy of a lifestyle intervention delivered entirely via an online social network to a traditional lifestyle intervention delivered via group meetings.

Primary Outcome

A digital scale (Scaletronix, Model-5002) will be used to record weight

Interventions

  • DEVICE Smartphone
  • BEHAVIORAL Traditional
  • BEHAVIORAL Get Social

Trial Details

FieldValue
Enrollment Target 329 participants
Start Date 2016-04
Est. Completion 2020-02-26
Phase NA
University of Connecticut

107 total trials

What the finished NCT02646618 record still lists

NCT02646618 is an interventional study that assigns participants to a tested intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 3 interventions - of which Smartphone is the first listed.

NCT02646618 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02646618 about?

NCT02646618 is a clinical study titled "Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention". The present study is a non-inferiority trial comparing the efficacy of a lifestyle intervention delivered entirely via an online social network to a traditional lifestyle intervention delivered via group meetings.

What is the current status of trial NCT02646618?

This trial is currently completed. It is a NA study. The enrollment target is 329 participants. The study started on 2016-04. Estimated completion is 2020-02-26.

What interventions are being tested in trial NCT02646618?

The interventions under investigation include: Smartphone (DEVICE), Traditional (BEHAVIORAL), Get Social (BEHAVIORAL).

Who is sponsoring clinical trial NCT02646618?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02646618's enrollment target sits among peer trials

329 308th of 2000 higher than 1,693 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06036446 · 329 participants · NA

    LATe Cerclage in High-risk Pregnancies (LATCH)

  • NCT00359684 · 330 participants

    Use of Cysteamine in the Treatment of Cystinosis

  • NCT03817502 · 330 participants · Phase 3

    Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  • NCT03922724 · 330 participants · Phase 2

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02646618, the US trial registry maintained by the National Library of Medicine. NCT02646618 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.